Last synced on 25 April 2025 at 11:05 pm

Filler, Bone Void, Recombinant Platelet-Derived Growth Factor

Page Type
Product Code
Definition
For use as an alternative to autograft in hindfoot and ankle fusion procedures that require supplemental graft material, including tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.
Physical State
The product consists of 1.5, 3, 6, or 9 cc of beta-tricalcium phosphate in granule form and 1.5, 3, 6, or 9 ml of rhPDGF-BB (0.3 mg/ml) in liquid form. The two components are mixed in equal volumes prior to use.
Technical Method
The platelet-derived growth factor component is intended to function as a chemo-attractant and mitogen for cells that stimulate the repair and growth of new bone. The osteoconductive calcium phosphate component is intended to act as a scaffold for new bone growth.
Target Area
The product is utilized in the hindfoot and ankle for fusion procedures that include tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.
Review Panel
Orthopedic
Submission Type
Contact ODE
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code OYR is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.

Filler, Bone Void, Recombinant Platelet-Derived Growth Factor

Page Type
Product Code
Definition
For use as an alternative to autograft in hindfoot and ankle fusion procedures that require supplemental graft material, including tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.
Physical State
The product consists of 1.5, 3, 6, or 9 cc of beta-tricalcium phosphate in granule form and 1.5, 3, 6, or 9 ml of rhPDGF-BB (0.3 mg/ml) in liquid form. The two components are mixed in equal volumes prior to use.
Technical Method
The platelet-derived growth factor component is intended to function as a chemo-attractant and mitogen for cells that stimulate the repair and growth of new bone. The osteoconductive calcium phosphate component is intended to act as a scaffold for new bone growth.
Target Area
The product is utilized in the hindfoot and ankle for fusion procedures that include tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.
Review Panel
Orthopedic
Submission Type
Contact ODE
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code OYR is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.